Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia

Dwi Wanna May 30, 2026 0

In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Discover Molecular Switch Regulating Muscle Regeneration and Sarcopenia

Dwi Wanna May 8, 2026 0

The global demographic shift toward an ageing population has brought age-related health conditions to the forefront of medical research, with…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer Cachexia

Dwi Wanna Mar 24, 2026 0

As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…

Read More
Osaka Metropolitan University Researchers Develop Self Regulating Artificial Photosynthesis System to Produce Solar Fuel Without Battery StorageTWiV 1286: Clinical Update with Dr. Daniel GriffinYale Researchers Uncover Molecular Mechanism of Anti-Sperm Antibodies Providing New Pathways for Infertility Treatment and Contraceptive InnovationAtomic Scale Barriers Could Derail the Future of 2D Semiconductor Technology According to TU Wien Research
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ